0000950170-25-010537.txt : 20250129 0000950170-25-010537.hdr.sgml : 20250129 20250129163005 ACCESSION NUMBER: 0000950170-25-010537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250128 FILED AS OF DATE: 20250129 DATE AS OF CHANGE: 20250129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kowieski Mark CENTRAL INDEX KEY: 0002024869 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25569740 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 420 STEVENS AVENUE, SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-01-28 0001403708 Evoke Pharma Inc EVOK 0002024869 Kowieski Mark C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 false true false false Chief Financial Officer false Stock Option (Right to Buy) 4.45 2025-01-28 4 A false 13000 0 A 2035-01-27 Common Stock 13000 13000 D 1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date. /s/ Mark Kowieski 2025-01-29